New York, USA, May 27, 2025 (GLOBE NEWSWIRE) -- Liposarcoma Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 15+ Companies and 20+ Therapies | DelveInsight The liposarcoma treatment ...
In the past, clinical studies of soft tissue sarcoma have tended to recruit patients with all histologic subtypes, in part because of the rarity of the disease. Not surprisingly, these trials were ...
Benign: Not cancerous; does not invade nearby tissue or spread to other parts of the body. CT scan-A test using computers and X-rays to create images of various parts of the body. DNA: The ...
The approval of Halaven was based on an improvement in overall survival (OS) in a phase 3 study. The FDA has approved Halaven (eribulin mesylate) as a treatment for patients with advanced or ...
In a statement, the archdiocese said the 71-year-old cardinal has “well-differentiated liposarcoma, which is a non-aggressive ...
Q: Which doctor should I consult if I have a lump with increasing size and pain? A: If someone is having lump of increasing size and pain,one should first visit a general practitioner who will refer ...
The antitumor drug trabectedin demonstrated superior disease control compared with conventional chemotherapy among patients with advanced liposarcoma and leiomyosarcoma who failed after prior ...
Liposarcoma is a rare cancer of connective tissues that resemble fat cells under a microscope. Dedifferentiated liposarcoma (DDLS) is a high-grade subtype of liposarcoma that progresses from ...
Liposarcomas are a rare type of malignancy with a very heterogeneous morphological appearance and clinical course. The therapeutic approach is based on histopathological classification and is ...
Researchers at Hiroshima University have found that different levels of two molecules of the same family--TIMP-1 and TIMP-4--can influence prognosis of liposarcoma. High levels of TIMP-1 lead to a ...
If your liposarcoma treatment isn't working so well, your doctor might suggest you join a clinical trial. It's a way to try a new medicine that isn't available yet to everyone. Clinical trials are ...
Cardinal Robert McElroy plans to be back at work in Washington two weeks after his surgery, scheduled for Nov. 13.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback